Keros halts hypertension treatment trial on safety issues

(Reuters) – Keros Therapeutics said on Wednesday it would voluntarily halt testing of its experimental hypertension treatment due to safety concerns during a mid-stage trial.

(Reporting by Christy Santhosh in Bengaluru; Editing by Shilpi Majumdar)